Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis and Treated With Interferon-beta

Stopped Sponsor decision to prematurely stop the study, not linked to any safety concern.

Conditions

• Multiple Sclerosis Relapse

Interventions

• DRUG: Teriflunomide
• DRUG: Placebo (for teriflunomide)
• DRUG: Interferon-beta (IFN-beta)

Sponsor

Sanofi